Federated Hermes’s Antares Pharma, Inc. ATRS Stock Holding History

Federated Hermes’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,473	Closed	-$10K	–	2354
2022 Q1	$10K	Buy	2,473 +4	+0.2%	+$15	﹤0.01%	1895
2021 Q4	$9K	Sell	2,469 -3,127	-56%	-$10.9K	﹤0.01%	1946
2021 Q3	$20K	Sell	5,596 -42	-0.7%	-$170	﹤0.01%	1934
2021 Q2	$25K	Sell	5,638 -3	-0.1%	-$12	﹤0.01%	1914
2021 Q1	$23K	Buy	+5,641	New	+$24.4K	﹤0.01%	1944
2020 Q1	–	Sell	-80	Closed	-$1K	–	2400
2019 Q4	$1K	Buy	+80	New	+$327	﹤0.01%	2176

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Federated Hermes's ATRS Position: Q2 2022 in Review

Federated Hermes sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 2,473 shares — an estimated $10K sold.

Federated Hermes first reported a position in ATRS in Q4 2019 and held it in 6 quarters. The position peaked at $25K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Federated Hermes reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Federated Hermes sold 2,473 Antares Pharma, Inc. shares in Q2 2022, an estimated $10K.
Federated Hermes first reported a position in Antares Pharma, Inc. in Q4 2019 and held it in 6 quarters.
Federated Hermes's Antares Pharma, Inc. position peaked at $25K in Q2 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Federated Hermes's 13F filing for Q2 2022, filed 15 Aug 2022.